PUBLICATION
Discovery of novel arylpyridine derivatives for motile ciliogenesis
- Authors
- Lee, G.B., Chandrasekaran, G., Kim, H.J., Kim, P., Yoon, J., Choi, B.W., Lee, S.H., Lee, S.Y., Shin, D.S., Lee, B.H., Bae, M.A., Goughnour, P., Choi, E.Y., Choi, S.Y., Ahn, J.H.
- ID
- ZDB-PUB-240827-1
- Date
- 2024
- Source
- European Journal of Medicinal Chemistry 277: 116764116764 (Journal)
- Registered Authors
- Choi, Seok-Yong, Lee, So-Hyun
- Keywords
- Aryl pyridine, COPD, Motile cilia, Multiciliated cell, Zebrafish
- MeSH Terms
-
- Pyridines*/chemical synthesis
- Pyridines*/chemistry
- Pyridines*/pharmacology
- Forkhead Transcription Factors/metabolism
- Cilia*/drug effects
- Cilia*/metabolism
- Mice
- Animals
- Drug Discovery*
- Molecular Structure
- Dose-Response Relationship, Drug
- Humans
- Zebrafish*
- Structure-Activity Relationship
- Animals, Genetically Modified
- PubMed
- 39180945 Full text @ Eur. J. Med. Chem.
Citation
Lee, G.B., Chandrasekaran, G., Kim, H.J., Kim, P., Yoon, J., Choi, B.W., Lee, S.H., Lee, S.Y., Shin, D.S., Lee, B.H., Bae, M.A., Goughnour, P., Choi, E.Y., Choi, S.Y., Ahn, J.H. (2024) Discovery of novel arylpyridine derivatives for motile ciliogenesis. European Journal of Medicinal Chemistry. 277:116764116764.
Abstract
Motile cilia are crucial for maintaining healthy bodily functions by facilitating fluid transport and removing foreign substances or debris from the body. The dysfunction of motile cilia leads to ciliopathy. In particular, damage to the motile cilia of the airways can cause or worsen respiratory disease, making it an attractive target for therapeutic interventions. However, there are no treatments to induce motile ciliogenesis. Forkhead box transcription factor J1 (FOXJ1), the master regulator, has been implicated in motile cilia formation. Mice lacking the Foxj1 gene show loss of axoneme, a key component of cilia, that further highlights the importance of FOXJ1 in motile cilia formation. This prompted us to identify new small molecules that could induce motile ciliogenesis. A phenotype-based high-throughput screening (HTS) in a Tg(foxj1a:eGFP) zebrafish model was performed and a novel hit compound was identified. Among the synthesized compounds, compound 16c effectively enhanced motile ciliogenesis in a transgenic zebrafish model. To further test the efficacy of compound 16c on a mammalian airway system consisting of multiciliated cells (MCCs), ex vivo mice tracheal epithelial cell culture was adopted under an air-liquid interface system (ALI). Compound 16c significantly increased the number of MCCs by enhancing motile ciliogenesis. In addition, compound 16c exhibited good liver microsomal stability, in vivo PK profiles with AUC, and oral bioavailability. There was no significant inhibition of CYP and hERG, and no cell cytotoxicity was shown. In an elastase-induced COPD (chronic obstructive pulmonary disease) mouse model, compound 16c effectively prevented the development and onset of COPD. Taken together, compound 16c has great promise as a therapeutic agent for treating and alleviating motile ciliopathies.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping